Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2021 2
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Statistical biases due to anonymization evaluated in an open clinical dataset from COVID-19 patients.
Koll CEM, Hopff SM, Meurers T, Lee CH, Kohls M, Stellbrink C, Thibeault C, Reinke L, Steinbrecher S, Schreiber S, Mitrov L, Frank S, Miljukov O, Erber J, Hellmuth JC, Reese JP, Steinbeis F, Bahmer T, Hagen M, Meybohm P, Hansch S, Vadász I, Krist L, Jiru-Hillmann S, Prasser F, Vehreschild JJ; NAPKON Study Group. Koll CEM, et al. Sci Data. 2022 Dec 21;9(1):776. doi: 10.1038/s41597-022-01669-9. Sci Data. 2022. PMID: 36543828 Free PMC article.
Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON).
Appel KS, Nürnberger C, Bahmer T, Förster C, Polidori MC, Kohls M, Kraus T, Hettich-Damm N, Petersen J, Blaschke S, Bröhl I, Butzmann J, Dashti H, Deckert J, Dreher M, Fiedler K, Finke C, Geisler R, Hanses F, Hopff SM, Jensen BO, Konik M, Lehnert K, de Miranda SMN, Mitrov L, Miljukov O, Reese JP, Rohde G, Scherer M, Tausche K, Tebbe JJ, Vehreschild JJ, Voit F, Wagner P, Weigl M, Lemhöfer C; NAPKON Study Group. Appel KS, et al. Among authors: de miranda smn. Infection. 2024 Apr 8. doi: 10.1007/s15010-024-02226-9. Online ahead of print. Infection. 2024. PMID: 38587752
All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort.
Schons MJ, Caliebe A, Spinner CD, Classen AY, Pilgram L, Ruethrich MM, Rupp J, Nunes de Miranda SM, Römmele C, Vehreschild J, Jensen BE, Vehreschild M, Degenhardt C, Borgmann S, Hower M, Hanses F, Haselberger M, Friedrichs AK; LEOSS-study group. Schons MJ, et al. Infection. 2022 Apr;50(2):423-436. doi: 10.1007/s15010-021-01699-2. Epub 2021 Oct 8. Infection. 2022. PMID: 34625912 Free PMC article.
Correction to: All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort.
Schons MJ, Caliebe A, Spinner CD, Classen AY, Pilgram L, Ruethrich MM, Rupp J, Nunes de Miranda SM, Römmele C, Vehreschild J, Jensen BE, Vehreschild M, Degenhardt C, Borgmann S, Hower M, Hanses F, Haselberger M, Friedrichs AK; LEOSS-study group. Schons MJ, et al. Infection. 2022 Apr;50(2):437-438. doi: 10.1007/s15010-021-01727-1. Infection. 2022. PMID: 34913136 Free PMC article. No abstract available.
SARS-CoV-2 infection in chronic kidney disease patients with pre-existing dialysis: description across different pandemic intervals and effect on disease course (mortality).
Pilgram L, Eberwein L, Jensen BO, Jakob CEM, Koehler FC, Hower M, Kielstein JT, Stecher M, Hohenstein B, Prasser F, Westhoff T, de Miranda SMN, Vehreschild MJGT, Lanznaster J, Dolff S; LEOSS study group. Pilgram L, et al. Among authors: de miranda smn. Infection. 2023 Feb;51(1):71-81. doi: 10.1007/s15010-022-01826-7. Epub 2022 Apr 29. Infection. 2023. PMID: 35486356 Free PMC article.
[The COVID-19 Pandemic as an Opportunity and Challenge for Registries in Health Services Research: Lessons Learned from the Lean European Open Survey on SARS-CoV-2 Infected Patients (LEOSS)].
Pilgram L, Schons M, Jakob CEM, Claßen AY, Franke B, Tscharntke L, Schulze N, Fuhrmann S, Sauer G, de Miranda SMN, Prasser F, Stecher M, Vehreschild JJ. Pilgram L, et al. Among authors: de miranda smn. Gesundheitswesen. 2021 Nov;83(S 01):S45-S53. doi: 10.1055/a-1655-8705. Epub 2021 Nov 3. Gesundheitswesen. 2021. PMID: 34731893 German.
Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study.
Pilgram L, Appel KS, Ruethrich MM, Koll CEM, Vehreschild MJGT, de Miranda SMN, Hower M, Hellwig K, Hanses F, Wille K, Haselberger M, Spinner CD, Vom Dahl J, Hertenstein B, Westhoff T, Vehreschild JJ, Jensen BO, Stecher M. Pilgram L, et al. Among authors: de miranda smn. Infection. 2023 Aug;51(4):1033-1049. doi: 10.1007/s15010-023-01994-0. Epub 2023 Feb 10. Infection. 2023. PMID: 36763285 Free PMC article.